Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during Chemical Clearance of Acid Reflux. by Woodley, Frederick W et al.
UC San Diego
UC San Diego Previously Published Works
Title
Not All Children with Cystic Fibrosis Have Abnormal Esophageal Neutralization during 
Chemical Clearance of Acid Reflux.
Permalink
https://escholarship.org/uc/item/60x6d12q
Journal
Pediatric gastroenterology, hepatology & nutrition, 20(3)
ISSN
2234-8646
Authors
Woodley, Frederick W
Moore-Clingenpeel, Melissa
Machado, Rodrigo Strehl
et al.
Publication Date
2017-09-26
DOI
10.5223/pghn.2017.20.3.153
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
pISSN: 2234-8646 eISSN: 2234-8840
https://doi.org/10.5223/pghn.2017.20.3.153
Pediatr Gastroenterol Hepatol Nutr 2017 September 20(3):153-159 PGHNOriginal Article
PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION 
Not All Children with Cystic Fibrosis Have Abnormal Esophageal 
Neutralization during Chemical Clearance of Acid Reflux
Frederick W. Woodley*,†, Melissa Moore-Clingenpeel‡, Rodrigo Strehl Machado§, 
Christopher J. Nemastil∥, Sudarshan R. Jadcherla*,†,¶, Don Hayes Jr†,∥, Benjamin T. Kopp†,∥, 
Ajay Kaul**,††, Carlo Di Lorenzo*,†, and Hayat Mousa†,‡‡,§§ 
*Division of Gastroenterology, Hepatology and Nutrition, Nationwide Children’s Hospital, †Department of Pediatrics, 
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Purpose: Acid neutralization during chemical clearance is significantly prolonged in children with cystic fibrosis, com-
pared to symptomatic children without cystic fibrosis. The absence of available reference values impeded identi-
fication of abnormal findings within individual patients with and without cystic fibrosis. The present study aimed to 
test the hypothesis that significantly more children with cystic fibrosis have acid neutralization durations during chem-
ical clearance that fall outside the physiological range. 
Methods: Published reference value for acid neutralization duration during chemical clearance (determined using 
combined impedance/pH monitoring) was used to assess esophageal acid neutralization efficiency during chemical 
clearance in 16 children with cystic fibrosis (3 to ＜18 years) and 16 age-matched children without cystic fibrosis.
Results: Duration of acid neutralization during chemical clearance exceeded the upper end of the physiological range 
in 9 of 16 (56.3%) children with and in 3 of 16 (18.8%) children without cystic fibrosis (p=0.0412). The likelihood 
ratio for duration indicated that children with cystic fibrosis are 2.1-times more likely to have abnormal acid neutraliza-
tion during chemical clearance, and children with abnormal acid neutralization during chemical clearance are 
1.5-times more likely to have cystic fibrosis. 
Conclusion: Significantly more (but not all) children with cystic fibrosis have abnormally prolonged esophageal clear-
ance of acid. Children with cystic fibrosis are more likely to have abnormal acid neutralization during chemical 
clearance. Additional studies involving larger sample sizes are needed to address the importance of genotype, 
esophageal motility, composition and volume of saliva, and gastric acidity on acid neutralization efficiency in cystic 
fibrosis children.
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Fig. 1. Classic two-phase acid reflux episode. VC: volume clearance, CC: chemical clearance.
INTRODUCTION
Gastroesophageal reflux (GER) is a physiologic 
process that occurs in most individuals following a 
meal when the increased intra-abdominal pressure 
causes relaxation of the lower esophageal sphincter 
and subsequent release of gastric contents into the 
esophagus. Clearance of the refluxed bolus following 
a GER episode occurs in two phases. In the first 
phase, the rapid volume clearance removes the bulk 
of the refluxed bolus by peristalsis and gravity when 
positioned upright. In the second phase, chemical 
clearance restores the esophageal mucosa to pre-re-
flux conditions [1]. During chemical clearance of 
acid GER (AGER) episodes, the acidified esophageal 
mucosa is neutralized by swallowed bicarbonate-rich 
saliva [2] and/or by bicarbonate secreted into the 
esophageal lumen from esophageal submucosal 
glands within the esophageal body [3-8]. In healthy 
individuals, these processes occur efficiently and in a 
timely manner. GER disease (GERD) occurs when 
physiological GER results in symptoms, such as 
heartburn, coughing and choking, laryngitis, diffi-
culty swallowing, vomiting, and chronic pulmonary 
infections. Studies in infant humans [9], adult hu-
mans [10,11] and in animals [11] suggest that im-
paired chemical clearance may be a primary patho-
physiological mechanism for GERD. Acid neutraliza-
tion is achieved when the acidified esophageal mu-
cosa reaches pH 4 [12]. Fig. 1 depicts a classic AGER 
episode as measured using combined multichannel 
intraluminal impedance and pH (MII-pH) monitoring.
Children with cystic fibrosis (CF) are known to 
have increased GER, presumably due to the dynam-
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ics that predispose this patient population to GER; 
these include frequent coughing, hyperinflation of 
the chest causing an increased pressure gradient be-
tween the chest abdomen, delayed gastric emptying, 
high-fat diets, frequent feedings (grazing), and vest 
treatments used to break up the mucous in the air-
ways [13,14]. All of these can cause the lower esoph-
ageal sphincter to relax and release gastric contents 
into the esophagus. 
In a study aimed at comparing GERD children 
with and without CF using combined MII-pH mon-
itoring, we reported that while the impedance met-
rics appeared to be similar between the two cohorts, 
the duration of acid neutralization during chemical 
clearance was significantly prolonged in the CF co-
hort (123 seconds vs. 66 seconds, p=0.001) [15]. 
Unfortunately, the study was limited by the absence 
of available acid neutralization reference values that 
could be used to assess individual subjects for abnor-
mal findings.
Using data derived from symptomatic children 
(ages 1 to ＜18 years) who were referred for symp-
toms suggestive of GER as an etiology, but had AGER 
in the normal physiologic range (＜3%) and had no 
significant symptom-GER associations, we derived 
reference values for acid neutralization during 
chemical clearance [16]. 
Based on our previous study showing significantly 
prolonged acid neutralization during chemical clear-
ance in children with CF compared to children with-
out CF [17], we hypothesized that children with CF 
would be significantly more likely to have acid neu-
tralization during chemical clearance that was out-
side of the physiological range. The present study 
aimed to use the published reference value for acid 
neutralization duration [15] to: 1) identify indi-
vidual patients (within both groups) for whom the 
duration of acid neutralization during chemical clea-
rance was outside the physiological range, 2) de-
termine whether symptomatic children with CF 
were more likely to have "abnormal" acid neutraliza-
tion during chemical clearance, and 3) assess the 
prospective predictive potential of the acid neutrali-
zation duration for identifying previously undiag-
nosed CF children.
MATERIALS AND METHODS
Study population
This study included 16 children with CF (3 to＜18 
years) and 16 age-matched children without CF. 
Previously calculated mean durations for each pa-
tient [15] were compared to the recently published 
acid neutralization duration reference value [16]. 
Median duration for both cohorts was also compared 
to the published reference value. Acid neutralization 
durations were calculated using MII-pH monitoring 
[15].
For both CF and non-CF cohorts, mean values (for 
acid neutralization duration) that exceeded the 
physiologically normal range were considered 
abnormal. The published threshold value was 114.4 
seconds for acid neutralization. 
Analysis
All analyses were conducted using SAS ver. 9.3 
(SAS Institute, Cary, NC, USA) with two-sided p-val-
ues ＜0.05 considered to be significant. Since CF pa-
tients were matched by age to non-CF patients, 
McNemar’s test for paired proportions was used to 
determine whether CF patients were more likely to 
have abnormal acid neutralization (duration) during 
chemical clearance. Area under the receiver operator 
characteristic curve (AUC), sensitivity, specificity, 
and likelihood ratio statistics were computed for us-
ing acid neutralization (duration) to potentially di-
agnose CF. Median (25th-75th quartile) values for 
CF and non-CF cohorts were compared using signed 
rank test.
The proportion of abnormal acid neutralization 
during chemical clearance was compared by CF sta-
tus using chi-square and Fisher’s exact tests. This 
part of the design was no longer a case-control study, 
since the matching was done by exposure and not 
outcome, and thus a paired analysis was not used.
This study was approved by the Institutional 
Review Board at Nationwide Children’s Hospital pri-
or to its execution (IRB no. 08-00195).
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Table 1. Patient Demographics
Variable CF (n=16) Non-CF (n=16)
Age (y) 8.2 (3.1-17.7) 8.3 (3.0-17.2)
Sex, male 6 (37.5) 9 (56.3)
Race
  Caucasian 16 (100) 14 (87.5)
  African American 0 (0) 2 (12.5)
CF genotype
  F508del/F508del 10 (62.5) -
  F508del/other 4 (25.0) -
  Other/other 2 (12.5) -
Values presented as median (range) or number (%).
CF: cystic fibrosis.
Table 3. Predictive Performance
Acid 
neutralization
Threshold 
(sec)
CF status 
on CC
CC status 
on CF
AUC LR AUC
Sen
(%)
Spc
(%)
LR
Duration 114.4 0.70 2.1 0.69 75 65 1.5
CF: cystic fibrosis, CC: chemical clearance, AUC: area under 
the receiver operator characteristic curve, LR: likelihood ratio,
Sen: sensitivity, Spc: specificity.
Table 2. Abnormal Chemical Clearance by Cystic Fibrosis 
Status
   Acid 
neutralization
Normal 
(n=20) 
Abnormal 
(n=12)
p-value
Duration Non-CF 13 (65.0) 3 (25.0) 0.0412
CF  7 (35.0) 9 (75.0)
Values are presented as number (%).
CF: cystic fibrosis.
RESULTS
Brief demographics of the cohort are included in 
Table 1, and a full description of subject symptoms 
have been previously published [15]. When we com-
pared the median durations of acid neutralization 
during chemical clearance to the reference value 
(114.4 seconds) (123 seconds [CF] vs. 66 seconds 
[non-CF]), acid neutralization during chemical 
clearance was abnormal for children with CF but 
normal for the children without CF.
When a 114.4 seconds threshold duration was 
used to assess CF and non-CF cohorts, 9 of 16 (56.3%) 
children with CF and 3 of 16 (18.8%) children with-
out CF were determined to have abnormal durations 
(p=0.0412, Table 2). 
We also found that a greater proportion of CF pa-
tients had abnormal acid neutralization during 
chemical clearance when we considered abnormal 
acid neutralization as a function of CF status (Table 
3). CF status has fairly good ability to discriminate 
between patients who have normal vs. abnormal 
acid neutralization during chemical clearance 
(AUC=0.70). Based on likelihood ratio values (positive 
test), patients with CF are 2.1-times more likely to 
have abnormal acid neutralization during chemical 
clearance when duration is considered (Table 3). 
The duration of acid neutralization during chem-
ical clearance discriminate moderately well between 
CF and non-CF patients, as evidenced by the rela-
tively high AUC value (0.69). If duration of acid neu-
tralization during chemical clearance were used as a 
biomarker to identify CF, it would have sensitivity 
(true positive) of 75% and specificity (true negative) 
of 65%. The likelihood ratio (positive) for acid neu-
tralization duration indicates that patients with ab-
normal acid neutralization during chemical clear-
ance are 1.5-times more likely to have a CF diagnosis. 
DISCUSSION
Hundreds of children are referred to our facility 
annually for symptoms suggestive of GER as an 
etiology. Among them are children with CF. Given 
that children with CF are known to have increased 
GER [18], we have sought to outline the differences 
between symptomatic children with and without CF 
so that we can differentiate and treat the children 
with CF appropriately and expeditiously. In a pre-
vious study, we compared two symptomatic pedia-
tric cohorts (CF and non-CF) and found that while 
the majority of impedance parameters were not dif-
ferent between the two groups, the duration of acid 
neutralization during chemical clearance was sig-
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nificantly prolonged in the CF cohort [15]. 
Unfortunately, at the time of the study, there were 
no available reference values for acid neutralization 
during chemical clearance. Consequently, we had no 
way of knowing: 1) whether the prolonged acid neu-
tralization was outside the physiologic range (i.e., 
abnormally prolonged), and 2) whether some or all 
children with CF had abnormal acid neutralization 
during chemical clearance. To fill this gap, we sub-
sequently derived reference values for acid neutrali-
zation during chemical clearance [16]. 
The results of the present study show that not all 
children with CF have abnormally prolonged acid 
neutralization during chemical clearance. Children 
with CF, however, are more likely to have abnormal 
acid neutralization during chemical clearance. Given 
the fact that delays in acid neutralization during 
chemical clearance are likely to be the pathophysio-
logical mechanism of GERD [9,10,19-21], our data 
indicating that children with CF are more likely to 
have prolonged acid neutralization during chemical 
clearance (2.1-times when considering acid neutrali-
zation duration) supports a clinical approach such 
that children with CF who present with GERD symp-
toms would likely benefit from acid neutralization 
assessment. 
A review of the literature reveals that there is a 
population of CF patients who are not diagnosed in 
infancy using the CF newborn screening test for im-
munoreactive trypsinogen. These individuals, roughly 
1.7-5.4% of the total, are identified at older ages and 
with varying severity of illness [22]. Given our initial 
observation that CF children (as a group) have pro-
longed acid neutralization during chemical clear-
ance [15], we hypothesized that assessments of acid 
neutralization during chemical clearance could be 
used to identify previously undiagnosed CF children. 
While prolonged acid neutralization duration during 
chemical clearance may not be diagnostic of CF 
(sensitivity 75% and specificity 65%), the combined 
results of this study suggest that further CF evalua-
tion should be considered in children with prolonged 
acid neutralization; particularly, in children who 
present with any of the common CF disease sequelae 
or history, such as nasal polyp removal, recurring 
pneumonias, etc. Other recent studies suggest that 
prolonged acid exposure may be related to the pro-
gression of mucosal damage during GERD [9-11,23], 
suggesting a mechanism for esophageal injury in CF 
patients with prolonged acid neutralization during 
chemical clearance.
In this and in previous studies [15,24], we as-
sessed chemical clearance by evaluating acid neu-
tralization during chemical clearance of AGER. Acid 
neutralization is but one component of chemical 
clearance, i.e., the period during which the esoph-
ageal mucosa is being returned to pre-reflux conditions. 
While efficient acid neutralization is important for 
preventing esophageal mucosal damage, removal of 
injurious gastric and duodenal molecules, such as 
pepsin and bile acids, is equally important. Recently, 
a novel pH-impedance parameter has been used to 
assess chemical clearance in adults. This parameter, 
known as the post-reflux swallow-induced peri-
staltic wave (PSPW) index, describes the percentage 
of total impedance-detected GER episodes during 
which the first post-reflux peristaltic wave (a swal-
low) occurs within 30 seconds [10,25]; the higher 
the PSPW index, the more efficient the chemical 
clearance. This new method shows promise for as-
sessment of chemical clearance during acid, weakly 
acidic, and weakly alkaline GER episodes. Further 
work is needed to assess the efficacy of these im-
pedance-pH parameters for assessing chemical clear-
ance in children. Being able to identify children with 
abnormal chemical clearance, by either assessing 
acid neutralization or by calculations of PSPW 
Indices, will permit timely implementation of appro-
priate clinical management strategies for sympto-
matic children with and without CF. 
This study has some limitations. First, the sample 
size is small. It is clear that the statistics would have 
benefited from a larger sample size. The narrow 
group of CF genotypes was also unfortunate. It is 
possible that our observations are unique to the pres-
ent study and cannot be extrapolated to other pa-
tient populations. Second, the chemical clearance 
reference used to assess the patient values were gen-
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erated using symptomatic patients who had a neg-
ative pH probe result on the day of testing. Because it 
is unethical to use healthy children (for whom im-
pedance-pH is not clinically indicated) to generate 
true normal values, we are forced to consider refer-
ence values derived from symptomatic children with 
normal impedance-pH studies. Finally, analyses of 
impedance-pH tracings were not blinded to patient 
genotype. Other studies involving larger samples sizes 
are needed to confirm the validity and subsequent 
utility of acid neutralization reference values. Addi-
tional studies involving larger samples sizes and 
wider varieties of genotypes are needed to fully as-
sess the potential impact of genotype on the effi-
ciency of acid neutralization during chemical clearance.
In summary, the data indicate that while children 
with CF are more likely to have abnormal acid neu-
tralization during chemical clearance compared to 
children without CF, not all children with CF have 
acid neutralization during chemical clearance that is 
outside the physiological range. It is possible that 
particular CF transmembrane conductance regulator 
(CFTR) genotypes, in combination with non-CFTR-
genetic modifiers and environmental factors, influ-
ence acid neutralization efficiency in children with 
CF [26,27]. It is possible that different CFTR geno-
types may influence the efficiency of acid neutraliza-
tion by reducing the efficiency of esophageal mo-
tility, by reducing the volume or changing the com-
position of the saliva, or possibly by increasing gas-
tric acidity. Further investigation involving larger 
sample sizes are needed to address these questions.
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